Jun Yong Kang (Chemistry and Biochemistry) has been granted by the U.S. Patent and Trademark Office for the invention “Chiral n-heterocyclic phosphorodiamidic acids (NHPAS) and derivatives as novel bronsted acid catalysts” This invention describes new synthetic methods of novel NHPA organocatalysts, which enable efficient synthesis of diaryl and arylalkyl phosphonates, key intermediates in the synthesis of phosphonate prodrugs, antibacterial agents, chemiluminescence materials, and flame retardants. This patent also claims the activation of ortho-quinone methides to versatile building blocks of pharmaceuticals and other biologically significant small molecules.
People in the News

People
| June 30, 2025
Candyann Humphries Reminds Us It's About the 'Care' in Healthcare
The Classified Employee of the Year's positive outlook and warm approach helps her colleagues in otolaryngology to thrive.

People
| June 24, 2025
From Startups to Stethoscopes
As a medical student with an entrepreneurial spirit, Edozie Ezeanolue envisions technology transforming the future of healthcare.

People
| June 23, 2025
Breann Wickson Fosters a Positive Campus Culture
The second place winner of the 2024 Classified Employee of the Year award winner goes the extra mile to make 51ԹϺ a better place.